|
Delayed
Bombay S.E.
04:52:35 04/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,946.95 INR | +0.40% |
|
-5.12% | +19.26% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 3,081 | +4.96% | 4 | ||||||
| 1,315.04 | +13.4% | 29 | ||||||
| 275.64 | -1% | 22 | ||||||
| 276.59 | +6.29% | 29 | ||||||
| 370.31 | +3.87% | 18 | ||||||
| 154.38 | -5.08% | 21 | ||||||
| 212.82 | +29.44% | 22 | ||||||
| 388.48 | -12.53% | 29 | ||||||
| 309.73 | +2.71% | 23 | ||||||
| 157.41 | +4.09% | 27 | ||||||
| 28.61 | -0.71% | 26 | ||||||
| 569.54 | +2.08% | 26 | ||||||
| 66.21 | -2.76% | 24 | ||||||
| 94.28 | +23.61% | 23 | ||||||
| 21.69 | +16.2% | 20 | ||||||
| 9,323.33 | +35.55% | 15 | ||||||
| 6,559.56 | +11.03% | 16 | ||||||
| 57.39 | +16.31% | 18 | ||||||
| 71.35 | +55.25% | 17 | ||||||
| 41.6 | +13.6% | 10 | ||||||
| Average | 1,168.75 | +10.82% | 21 | ||||||
| Weighted average by Cap. | 709.03 | +7.08% | 24 |
Select your edition
All financial news and data tailored to specific country editions
